Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

People taking GLP-1 medications like semaglutide often ask whether they can continue creatine supplementation during treatment. The short answer is conditional: kidney function and hydration levels matter most. GLP-1 drugs slow gastric emptying and can reduce daily fluid intake, creating a different metabolic environment than creatine use typically assumes.

How Creatine Works and Why GLP-1 Users Ask

Creatine monohydrate is one of the most studied sports supplements on the market, used primarily by people building or maintaining muscle mass. It works by increasing phosphocreatine stores in muscle cells, which supports energy production during intense training. When someone begins GLP-1 therapy, appetite suppression and reduced calorie intake can trigger muscle loss alongside fat loss—a concern that makes creatine supplementation seem beneficial.

However, creatine increases intramuscular water retention and places modest metabolic demand on the kidneys. Both factors become relevant when GLP-1 medications alter hydration patterns and appetite-driven fluid consumption. The combination is not necessarily dangerous, but it requires conscious management of water intake and baseline kidney health assessment.

GLP-1 Effects on Kidney Function and Hydration

GLP-1 receptor agonists slow stomach emptying and reduce appetite signals, leading many patients to drink less fluid throughout the day simply because thirst signals diminish. Dehydration is one of the most common side effects reported by semaglutide and tirzepatide users, particularly in the first 4–8 weeks of treatment. Adequate hydration is essential for kidney filtration and creatinine metabolism, the byproduct that clinicians measure when assessing kidney function.

Research in patients taking GLP-1 medications shows that baseline kidney function remains stable in most people, but those with pre-existing chronic kidney disease (CKD) require closer monitoring. Adding creatine supplementation to a state of mild dehydration creates unnecessary stress on filtration capacity. The kidneys must work harder to clear creatinine from circulation, potentially elevating serum creatinine levels and masking true kidney status.

Clinical Considerations for Combining Creatine and GLP-1 Therapy

Medical guidelines do not explicitly contraindicate creatine use in people taking GLP-1 medications, but nephrology experts recommend a stepwise approach. First, confirm baseline kidney function through serum creatinine and estimated glomerular filtration rate (eGFR) before starting either creatine or GLP-1 therapy. An eGFR above 60 mL/min/1.73m² is considered normal kidney function; below that threshold, creatine supplementation poses greater risk.

Second, prioritize hydration discipline. People on semaglutide or tirzepatide should aim for 8–10 glasses of water daily, even when thirst cues are suppressed. Third, use lower creatine doses (3–5 grams daily) rather than loading protocols (20 grams over 5–7 days), which concentrate acute kidney demands. Monitor serum creatinine every 3–6 months while on both substances, and communicate openly with your prescribing provider about supplement use.

Muscle Preservation Strategies During GLP-1 Weight Loss

Muscle loss during GLP-1 therapy typically results from calorie deficit and reduced protein intake—not from the medication itself. The most evidence-backed approach to preserving lean mass is consistent resistance training (2–3 sessions weekly) paired with adequate daily protein intake: 0.8–1.0 gram per pound of body weight. This strategy works independently of creatine supplementation and addresses the root driver of lean-mass loss.

If you choose to use creatine alongside semaglutide or tirzepatide, prioritize protein and training first. Creatine's muscle-building effects are modest without proper stimulus and nutrition. PlexusDx Semaglutide Injection (starting at $149/month) supports your weight loss foundation; pairing it with structured exercise and high protein intake delivers better muscle-sparing outcomes than any supplement alone. Some patients find that as appetite normalizes after the first 8 weeks on GLP-1 therapy, protein intake naturally increases, making supplemental creatine less critical.

What PlexusDx Patients Should Know About Safety Screening

Before starting any GLP-1 medication from PlexusDx, baseline kidney function assessment is standard medical practice. PlexusDx compounded semaglutide and tirzepatide come from licensed 503A compounding pharmacies and are customized to individual tolerance, but they do not eliminate the need for standard lab work. If you are considering creatine supplementation, disclose that to your PlexusDx provider during the initial consultation so kidney function can be properly evaluated.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after the first month of treatment), which maps 14 metabolic pathways and 49 peptides relevant to weight loss and muscle metabolism. While this test does not directly assess creatine metabolism, understanding your genetic predispositions for muscle response and metabolic efficiency helps inform whether creatine supplementation aligns with your individual physiology during GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take creatine while on semaglutide?

Creatine and semaglutide can be combined safely in most people with normal kidney function, but requires intentional hydration (8–10 glasses daily) and baseline kidney testing. PlexusDx ensures kidney function is assessed before starting semaglutide; discuss creatine use with your provider so monitoring can be adjusted accordingly.

Does creatine increase kidney damage risk on GLP-1 medications?

Creatine itself does not cause kidney damage, but it increases serum creatinine levels (a kidney function marker) and requires adequate hydration for safe metabolism. GLP-1 medications reduce thirst cues and daily fluid intake, creating conditions where creatine's kidney demands are harder to meet. Those with eGFR below 60 should avoid creatine while on GLP-1 therapy.

How much will semaglutide cost through PlexusDx?

PlexusDx Compounded Semaglutide Injection starts at $149/month and is available in all 50 states without insurance or membership fees. Your dose may need to go up. Your price won't. HSA and FSA accounts are accepted, making it accessible for most budgets.

Can creatine prevent muscle loss during GLP-1 weight loss?

Creatine has modest muscle-sparing effects only when paired with resistance training and adequate protein intake—the real drivers of lean-mass preservation. During GLP-1 therapy, prioritize strength training 2–3 times weekly and 0.8–1.0 gram of protein per pound of body weight. Creatine is a secondary tool, not a primary solution.

Does PlexusDx genetic testing help with supplement decisions?

The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across 49 peptides and 14 metabolic pathways, including variants affecting muscle response and metabolic efficiency. While it does not assess creatine metabolism directly, it informs whether your genetic profile suggests strong muscle-building capacity—data that helps decide if creatine supplementation fits your personalized weight loss plan.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves